Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts

Circulation

Volumn 127, Issue 12, 2013, Pages 1290-1299

  Atkinson, Carl ^a   Floerchinger, Bernhard ^b,c   Qiao, Fei ^a   Casey, Sarah ^a   Williamson, Tucker ^a   Moseley, Ellen ^d   Stoica, Serban ^d,e   Goddard, Martin ^d   Ge, Xupeng ^f   Tullius, Stefan G ^b   Tomlinson, Stephen ^a,g  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d PAPWORTH HOSPITAL   (United Kingdom)

^e BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Inflammation; Ischemia; Reperfusion injury; Transplantation

Indexed keywords

COMPLEMENT; COMPLEMENT INHIBITOR; TROPONIN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEATH; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVING DONOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ADOLESCENT; ADULT; ANIMALS; BIOPSY; BRAIN DEATH; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; FEMALE; HEART; HEART TRANSPLANTATION; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MIDDLE AGED; MODELS, ANIMAL; MYOCARDIUM; RECOMBINANT FUSION PROTEINS; REPERFUSION INJURY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS; YOUNG ADULT;

EID: 84875435866     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.000784     Document Type: Article

References (36)

1. Luckraz H, Charman SC, Parameshwar J, Tsui SS, Dunning J, Wallwork J, Large SR. Are non-brain stem-dead cardiac donors acceptable donors? J Heart Lung Transplant. 2004;23:330-333.
2. Mehra MR, Uber PA, Ventura HO, Scott RL, Park MH. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol. 2004;43:806-810.
3. Szabo G, Buhmann V, Bahrle S, Vahl CF, Hagl S. Brain death impairs coronary endothelial function. Transplantation. 2002;73:1846-1848.
4. Damman J, Seelen MA, Moers C, Daha MR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ. Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation. 2011;92:163-169.
5. Okamoto R, Yamamoto Y, Lin H, Ueda J, Yokoyama T, Tanaka K, Shimahara Y, Mori K, Kumada K, Yamaoka Y. Influence of dopamine on the liver assessed by changes in arterial ketone body ratio in brain-dead dogs. Surgery. 1990;107:36-42.
6. Galiñanes M, Hearse DJ. Brain-death-induced cardiac contractile dysfunction: studies of possible neurohormonal and blood-borne mediators. J Mol Cell Cardiol. 1994;26:481-498.
7. Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation. 1998;65:1533-1542.
8. Takada M, Nadeau KC, Shaw GD, Marquette A, Tilney NL. The cytokineadhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. J.Clin.Invest. 1997;99:2682-2690.
9. Kusaka M, Zandi-Nejad K, Kato S, Beato F, Nagano H, Shaw GD, Tilney NL. Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness: indefinite kidney allograft survival by treatment with a soluble P-selectin ligand and low-dose cyclosporine in combination. Transplantation. 1999;67:1255-1261.
10. Riedemann NC, Ward PA. Complement in ischemia reperfusion injury. Am J Pathol. 2003;162:363-367.
11. Hartmann K, Henz BM, Krüger-Krasagakes S, Köhl J, Burger R, Guhl S, Haase I, Lippert U, Zuberbier T. C3a and C5a stimulate chemotaxis of human mast cells. Blood. 1997;89:2863-2870.
12. Fernandez HN, Henson PM, Otani A, Hugli TE. Chemotactic response to human C3a and C5a anaphylatoxins, I: evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol. 1978;120:109-115.
13. Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE, Lambris JD. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med. 2003;198:913-923.
14. Damman J, Schuurs TA, Ploeg RJ, Seelen MA. Complement and renal transplantation: from donor to recipient. Transplantation. 2008;85:923-927.
15. Damman J, Daha MR, Leuvenink HG, van Goor H, Hillebrands JL, Dijk MC, Hepkema BG, Snieder H, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Seelen MA. Association of complement C3 gene variants with renal transplant outcome of deceased cardiac dead donor kidneys. Am J Transplant. 2012;12:660-668.
16. Damman J, Daha MR, van Son WJ, Leuvenink HG, Ploeg RJ, Seelen MA. Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury. Am J Transplant. 2011;11:660-669.
17. Damman J, Hoeger S, Boneschansker L, Theruvath A, Waldherr R, Leuvenink HG, Ploeg RJ, Yard BA, Seelen MA. Targeting complement activation in brain-dead donors improves renal function after transplantation. Transpl Immunol. 2011;24:233-237.
18. Pratschke J, Wilhelm MJ, Kusaka M, Laskowski I, Tilney NL. A model of gradual onset brain death for transplant-associated studies in rats. Transplantation. 2000;69:427-430.
19. Damman J, Nijboer WN, Schuurs TA, Leuvenink HG, Morariu AM, Tullius SG, van Goor H, Ploeg RJ, Seelen MA. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. Nephrol Dial Transplant. 2011;26:2345-2354.
20. Atkinson C, Varela JC, Tomlinson S. Complement-dependent inflammation and injury in a murine model of brain dead donor hearts. Circ Res. 2009;105:1094-1101.
21. DeAngelis RA, Markiewski MM, Kourtzelis I, Rafail S, Syriga M, Sandor A, Maurya MR, Gupta S, Subramaniam S, Lambris JD. A complement- IL-4 regulatory circuit controls liver regeneration. J Immunol. 2012;188:641-648.
22. Markiewski MM, Mastellos D, Tudoran R, DeAngelis RA, Strey CW, Franchini S, Wetsel RA, Erdei A, Lambris JD. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol. 2004;173:747-754.
23. He S, Atkinson C, Qiao F, Cianflone K, Chen X, Tomlinson S. A complement- dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice. J Clin Invest. 2009;119:2304-2316.
24. Proctor LM, Moore TA, Monk PN, Sanderson SD, Taylor SM, Woodruff TM. Complement factors C3a and C5a have distinct hemodynamic effects in the rat. Int Immunopharmacol. 2009;9:800-806.
25. Atkinson C, Song H, Lu B, Qiao F, Burns TA, Holers VM, Tsokos GC, Tomlinson S. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J Clin Invest. 2005;115:2444-2453.
26. Atkinson C, He S, Morris K, Qiao F, Casey S, Goddard M, Tomlinson S. Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation. J Immunol. 2010;185:7007-7013.
27. Moseley EL, Atkinson C, Sharples LD, Wallwork J, Goddard MJ. Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy. J Heart Lung Transplant. 2010;29:417-423.
28. Stoica SC, Atkinson C, Satchithananda DK, Charman S, Goddard M, Redington AN, Large SR. Endothelial activation in the transplanted human heart from organ retrieval to 3 months after transplantation: an observational study. J Heart Lung Transplant. 2005;24:593-601.
29. Kusaka M, Pratschke J, Wilhelm MJ, Ziai F, Zandi-Nejad K, Mackenzie HS, Hancock WW, Tilney NL. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation. 2000;69:405-410.
30. Gasser M, Waaga AM, Kist-Van Holthe JE, Lenhard SM, Laskowski I, Shaw GD, Hancock WW, Tilney NL. Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand. J Am Soc Nephrol. 2002;13:1937-1945.
31. Gasser M, Waaga-Gasser AM, Grimm MW, Grimm MR, Lenhard MS, Kist-van Holthe JE, Laskowski I, Shaw GD, Thiede A, Hancock WW, Tilney NL. Selectin blockade plus therapy with low-dose sirolimus and cyclosporin a prevent brain death-induced renal allograft dysfunction. Am J Transplant. 2005;5(pt 1):662-670.
32. Cantin B, Kwok BW, Chan MC, Valantine HA, Oyer PE, Robbins RC, Hunt SA. The impact of brain death on survival after heart transplantation: time is of the essence. Transplantation. 2003;76:1275-1279.
33. Anyanwu AC, Banner NR, Mitchell AG, Khaghani A, Yacoub MH. Low incidence and severity of transplant-associated coronary artery disease in heart transplants from live donors. J Heart Lung Transplant. 2003;22:281-286.
34. Pratschke J, Tullius SG, Neuhaus P. Brain death associated ischemia/reperfusion injury. Ann Transplant. 2004;9:78-80.
35. Gasser M, Waaga AM, Laskowski IA, Tilney NL. The influence of donor brain death on short and long-term outcome of solid organ allografts. Ann Transplant. 2000;5:61-67.
36. Pratt JR, Jones ME, Dong J, Zhou W, Chowdhury P, Smith RA, Sacks SH. Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol. 2003;163:1457-1465.